Katie Price reveals 28st Harvey ‘can’t put his shoes on without sweating’ and faces MORE surgery after Ozempic jabs

KATIE Price's 28 stone son faces more surgery after going on Ozempic jabs. And Harvey's terrified mum fears the 22-year-old may die of a heart attack without help. The TV personality's eldest child, who has Prader-Willi syndrome, struggles to dress himself due to his size. Katie told The Sun she consulted top doctors who suggested starting Harvey on the jabs in a bid to improve his chances of living longer.

She said: “He’s putting on weight. It doesn’t matter what we do. “He can’t put his shoes on without sweating. He can’t walk far because he gets out of breath. "It’s because of all the weight. So the doctors are doing it to give him a better, longer life, and for his health.". Great Ormond Street Hospital have made an exception for Harvey by continuing to treat him, even though he's an adult.

He's already on a lot of medication but Katie says the weight loss jabs won't interfere with those. He'll be on the jabs for up to two years - which is the maximum current regulations allow. When he loses the weight he may need surgery to cut away pounds of loose skin. Katie said: "They want to try him on it for at least one or two years, which is a long time, but they’ll control what level he needs then up it as they assess it.".

Brave Katie was recently forced to deny she has used the so-called 'skinny jabs' after fans raised concerns over her appearance. But she has revealed the "real reason" behind her weight loss, attributing it to a change in diet and a more active lifestyle - after gaining weight on IVF and being inactive after breaking her foot in 2020. On the latest episode of The Katie Price Show podcast, she said: "Everyone has said I've got skinny now ...

"My go to breakfast is two boiled eggs and soldiers.". Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club. Dr Mitra Dutt, a GP from Lloyds Pharmacy Online Doctor, says: “Mounjaro works by activating two hormonal receptors (GIP and GLP-1), which enhance insulin production, improve insulin sensitivity and work to decrease food intake.”. Saxenda, which contains the active ingredient liraglutide, is another weight loss jab that's been available on the NHS since 2020.

While Mounjaro is hailed as the "King Kong" fat jabs, a new weight loss drug dubbed "Godzilla" looks set to displace it. Containing the active ingredient retatrutide, slimmers trying the drug lost up to 29 per cent of their weight in less than a year. By comparison, trial results showed semaglutide, known as Ozempic, could lead to 15 per cent weight loss and tirzepatide, aka Mounjaro, to 23 per cent.